Nektar Therapeutics reports results for the quarter ended in September 30 - Earnings Summary

Nektar Therapeutics

08/11/2024 04:39

* Nektar Therapeutics  NKTR.OQ  reported a quarterly
adjusted loss
of 18 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -24 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 21 cents per
share. Wall Street expected results to range from -26 cents
to -16 cents per share.
    * Revenue fell 0.1% to $24.12 million from a year ago;
analysts
expected $18.28 million. 
    * Nektar Therapeutics's reported EPS for the quarter was a
loss
of 18 cents​.
    * The company reported a quarterly loss of $37.06 million.
    * Nektar Therapeutics shares had risen by 6.9% this
quarter and
gained 146.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Nektar
Therapeutics is 4.00 
This summary was machine generated from LSEG data November 8 at
04:38 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.21          -0.18          Beat
 Jun. 30 2024      -0.20          -0.25          Missed
 Mar. 31 2024      -0.19          -0.19          Met
 Dec. 31 2023      -0.21          -0.22          Missed